Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Analysis: Film-Maker Fujifilm To Enter Japan Drug Business with Toyama Chemical Acquisition

This article was originally published in PharmAsia News

Executive Summary

Fujifilm Holdings' bid to buy Toyama Chemical signals a move by companies with technologies beneficial to drug making to enter the pharmaceutical market. Ajinomoto, in the seasoning and food business, relies on fermentation technologies for its amino acid-based drugs, and Toray Industries applies biotechnology and nanotechnology to help develop drugs with long-lasting effects. Japan Pharmaceutical Manufacturers Association President Hatsuo Aoki said his industry expects to see an increase in mergers and acquisitions centered on certain technologies rather than company size. (Click here for more - a subscription may be required

Related Content

Fujifilm’s Tender Offer for Toyama Chemical Begins (Part 1 Of 2)
Taisho To Enter Lactic Acid Market With Biofermin Acquisition



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts